Study of the CycloPen Micro-Interventional System and Long-Term Clinical Outcomes
Part of paid clinical trials in Newport Beach, California.
- Sponsor
- Iantrek, Inc.
- Study ID
- NCT05506423
- Status
- Enrolling By Invitation
Conditions
Eligibility Criteria
- Sex
- ALL
- Age
- 21 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- CycloPen Cyclodialysis System — DEVICEThe CycloPen Micro-Interventional Cyclodialysis System is used to create and cyclodialysis cleft and deliver allograft scleral tissue and/or viscous material to reinforce and maintain the cleft postoperatively.
Study Details
This observational study will enroll adults with open angle glaucoma (OAG) who had surgery to reduce intraocular pressure (IOP) using the CycloPen Micro-Interventional System. Consenting participants will be followed for 24 months after their surgery. Data regarding IOP, use of glaucoma medications, and any side effects related to the surgery will be collected from participants' preoperative examination, their surgery, and postoperative examinations.
Key Dates
- Start date
- Aug 17, 2022
- Status verified
- Dec 2025
- Primary completion
- Aug 31, 2026
- Completion
- Aug 31, 2027
Study Design
- Enrollment
- 300 participants (estimated)
Arms
- Arm: CycloPen Cyclodialysis System in conjunction with cataract surgeryOphthalmic surgical intervention with the CycloPen Cyclodialysis System in conjunction with cataract surgery
- Arm: CycloPen Cyclodialysis System in standalone surgeryOphthalmic surgical intervention with the CycloPen Cyclodialysis System
Primary Outcome Measure
Percent of eyes with intraocular pressure (IOP) reduction ≥ 20% in comparison with baseline [ Time Frame: 12 months postoperative ]
Locations (15)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| CREST Site 05 | Newport Beach | California | 92663 | - |
| CREST Site 03 | Cape Coral | Florida | 33904 | - |
| CREST Site 10 | DeLand | Florida | 32720 | - |
| CREST Site 06 | Fort Myers | Florida | 33912 | - |
| CREST Site 07 | Atlanta | Georgia | 30342 | - |
| CREST Site 12 | Chevy Chase | Maryland | 20815 | - |
| CREST Site 13 | Rockville | Maryland | 20852 | - |
| CREST Site 16 | Las Vegas | Nevada | 89145 | - |
| CREST Site 14 | New Brunswick | New Jersey | 07728 | - |
| CREST Site 15 | New York | New York | 10034 | - |
| CREST Site 17 | Williamsville | New York | 14221 | - |
| CREST Site 01 | Fort Washington | Pennsylvania | 19034 | - |
| CREST Site 04 | Crossville | Tennessee | 38555 | - |
| CREST Site 09 | Fort Worth | Texas | 76102 | - |
| CREST Site 11 | Salt Lake City | Utah | 84132 | - |
Find similar trials in Newport Beach, CA
By condition
By specialty
Related Studies
- Safety and Effectiveness of Minimally Invasive Micro Sclerostomy (MIMS®) to Reduce Intraocular Pressure in Open-Angle Glaucoma Which is Not Controlled Despite PolypharmacyRecruiting · Sanoculis Ltd · Dallas, Texas
- Standalone iStent Infinite and iDose TR for Management of Moderate to Severe Open Angle GlaucomaPHASE4 · Recruiting · Jonathon Myers · Philadelphia, Pennsylvania
- Topical Insulin for Glaucoma (TING2)PHASE1/PHASE2 · Not Yet Recruiting · Stanford University · Palo Alto, California
- Efficacy of Simbrinza and Rocklatan vs Cosopt and LatanoprostPHASE4 · Recruiting · Prairie Eye Center · Springfield, Illinois